Hyperion Therapeutics Inc (NASDAQ:HPTX)

29.55
Delayed Data
As of Feb 27
 +1.82 / +6.56%
Today’s Change
20.23
Today|||52-Week Range
32.98
+23.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues18.6M19.5M37.1M26.2M
 
 
 
 
 
Cost of Goods Sold2.8M2.4M4.5M3.0M
 
 
 
 
 
Depreciation And Amortization1.8M1.1M1.1M1.6M
 
 
 
 
 
 
Operating ExpensesGross Income14.0M16.0M31.5M21.6M
 
 
 
 
 
General Expenses13.1M14.3M14.0M20.2M
 
 
 
 
 
Research And Development3.0M3.1M4.0M6.9M
 
 
 
 
 
Total Operating Expenses17.7M17.8M19.6M24.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income881.0K1.7M17.5M1.4M
 
 
 
 
 
Extraordinary Charge0.000.00-2.0M-30.8M
 
 
 
Interest Expense On Debt387.0K300.0K269.0K176.0K
 
 
 
 
 
Other Expenses18.0K-190.0K-4.0K-290.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income518.0K1.3M15.4M-29.8M
 
 
 
 
 
Income Taxes-49.0K-88.0K-2.1M-3.0M
 
 
 
 
 
Net Income469.0K1.3M17.5M-32.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.1M20.2M20.3M20.6M
 
 
 
 
 
Shares To Calculate EPS Diluted21.4M21.5M21.6M20.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.02$0.06$0.81-$1.59
 
 
 
 
 
EPS Diluted$0.02$0.06$0.81-$1.59
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account